Medical News

RSS

NHI acquires four assisted living and memory care communities for $15 million

National Health Investors, Inc. announced today it has closed a $15 million purchase of four assisted living and memory care communities totaling 183 units in Louisiana and has leased those communities to Selah SeniorCare III and managed by Selah Management Group. The purchase price was funded from NHI's revolving credit facility.

5 May 2011

Symmetry Medical first quarter revenue increases 13.4% to $95.8 million

Symmetry Medical Inc., a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced first quarter 2011 financial results for the period ended April 2, 2011.

5 May 2011

Pfizer’s Revatio receives European Commission approval for pediatric treatment of pulmonary arterial hypertension

Pfizer Inc. announced that Revatio (sildenafil citrate) has been approved by the European Commission for the treatment of pediatric patients aged 1 to 17 years old with pulmonary arterial hypertension. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease.

5 May 2011

Acorda reports $0.7 million GAAP net loss for first quarter 2011

Acorda Therapeutics, Inc. today announced its financial results for the first quarter ended March 31, 2011.

5 May 2011

PhotoMedex introduces DNA Damage Control sunscreens

PhotoMedex, Inc. a leading supplier of advanced, clinical skincare and medical laser products, today introduced DNA Damage Control, the breakthrough treatment sunscreens that feature advanced photoprotection with DNA repair technology.

5 May 2011

Promedior's PRM-151 clinical data in idiopathic pulmonary fibrosis to be presented at ATS 2011

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, today announced that data from a clinical study of PRM-151 will be presented at the 2011 American Thoracic Society International Conference, being held May 13-18, 2011 in Denver, CO.

5 May 2011

POZEN reports revenue of $4.5 million for first quarter 2011

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the first quarter ended March 31, 2011.

5 May 2011

Boston Business Journal honors Tufts Health Plan for Worksite Wellness program

Tufts Health Plan recently received the prestigious honor of being recognized for its Worksite Wellness initiatives by the Boston Business Journal. As a finalist in the Boston Business Journal's listing of "HEALTHIEST EMPLOYERS," the non profit company was recognized as an organization that is deeply committed to improving the health of its employees and its workplace.

5 May 2011

Biosense Webster enters new agreement with Stereotaxis to deploy Odyssey products

Stereotaxis, Inc. announced today that it has entered into a new strategic collaboration with Biosense Webster, Inc. related to Stereotaxis' rapidly growing Odyssey Solutions.

5 May 2011

Mylan launches Oxycodone and Aspirin Tablets for treatment of severe pain

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Oxycodone and Aspirin Tablets USP, 4.8355 mg/325 mg, based on an agreement with licensing partner Coastal Pharmaceuticals.

5 May 2011

First Edition: May 5, 2011

Kaiser Health News staff writer Jessica Marcy recently spoke with Dan Hawkins, the association's senior vice president, about the future and finances of community health centers and their evolving budgets.

5 May 2011

Researchers identify key mucus component in human gut that can kill parasitic worms

Scientists have discovered why some people may be protected from harmful parasitic worms naturally while others cannot in what could lead to new therapies for up to one billion people worldwide.

5 May 2011

ArQule reports net loss of $1,466,000 for first quarter 2011

ArQule, Inc. today announced its financial results for the first quarter of 2011.

5 May 2011

Researchers present evidence from first ever general population survey of autism in adulthood

Not a single person identified with autism or asperger's syndrome during a community survey in England actually knew they had the condition, research led by the University of Leicester reveals.

5 May 2011

The Miami Project, InVivo Therapeutics collaborate to develop novel spinal cord injury treatments

InVivo Therapeutics, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries, and The University of Miami Miller School of Medicine's Miami Project to Cure Paralysis, the world's most comprehensive spinal cord injury research center, today announced a strategic research collaboration for the development of novel SCI treatments.

5 May 2011

ZIOPHARM reports net loss of $39.0 million for first quarter 2011

ZIOPHARM Oncology, Inc, an oncology small molecule and synthetic biology drug development company, today reported its financial results for the three months ended March 31, 2011, and provided an update on the Company's activities in the first quarter.

5 May 2011

FDA releases final guidance to firms that market OTC drug products

The U.S. Food and Drug Administration today released its final guidance to firms that manufacture, market, or distribute over-the-counter liquid drug products packaged with cups, droppers, syringes, and spoons to measure and dispense the doses of medication.

5 May 2011

IOM study calls for increased oral health awareness in the U.S.

This is the point of a new report by the Institute of Medicine, Advancing Oral Health in America, which underscores a public health crisis that has persisted more than a decade after the U.S. Surgeon General called for aggressively reversing the "silent epidemic" of America's oral health disparity. Many of the most pernicious oral health diseases are highly preventable and treatable.

5 May 2011

Aerocrine reports net sales of SEK 22.2m for January - March, 2011

Aerocrine: January - March 2011: Net sales rose by 24% to SEK 22.2m. Adjusted for currency fluctuations, net sales rose by 38%

5 May 2011

Sonography can effectively diagnose Juvenile Inflammatory Arthritis

Juvenile Inflammatory Arthritis is a potentially debilitating childhood disease. Early detection and treatment of active arthritis may avert long term joint damage and disability.

5 May 2011